TCM Biotech International Corp. Statistics
TCM Biotech International Corp. (4169) Stock Statistics & Valuation Metrics
Total Valuation
TCM Biotech International Corp. has a market cap or net worth of TWD 7.54B. The enterprise value is TWD 13.28B.
- Market Cap
- TWD 7.54B
- Enterprise Value
- TWD 13.28B
Share Statistics
TCM Biotech International Corp. has 66,431,610 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 66,431,610
- Owned by Insiders
- ―
- Owned by Institutions
- 0.04%
Financial Efficiency
TCM Biotech International Corp.’s return on equity (ROE) is 0.02 and return on invested capital (ROIC) is 1.45%.
- Return on Equity (ROE)
- 0.02
- Return on Assets (ROA)
- 0.02
- Return on Invested Capital (ROIC)
- 1.45%
- Return on Capital Employed (ROCE)
- 0.02
- Revenue Per Employee
- 9.39M
- Profits Per Employee
- 262.60K
- Employee Count
- 73
- Asset Turnover
- 0.57
- Inventory Turnover
- 2.80
Valuation Ratios
The current PE Ratio of TCM Biotech International Corp. is -312.50. TCM Biotech International Corp.’s PEG ratio is 3.13.
- PE Ratio
- -312.50
- PS Ratio
- 9.50
- PB Ratio
- 4.25
- Price to FCF
- -3201.21
- Price to Operating Cash Flow
- 2189.30
- PEG Ratio
- 3.13
Income Statement
In the last 12 months, TCM Biotech International Corp. had revenue of 685.49M and earned 19.17M in profits. Earnings per share was 0.32.
- Revenue
- 685.49M
- Gross Profit
- 296.68M
- Operating Income
- 18.65M
- Pretax Income
- 22.30M
- Net Income
- 19.17M
- EBITDA
- 42.18M
- Earnings Per Share (EPS)
- 0.32
Cash Flow
In the last 12 months, operating cash flow was 3.79M and capital expenditures -6.39M, giving a free cash flow of -2.59M billion.
- Operating Cash Flow
- 3.79M
- Free Cash Flow
- -2.59M
- Free Cash Flow per Share
- -0.04
Dividends & Yields
TCM Biotech International Corp. pays an annual dividend of ―, resulting in a dividend yield of 0.28%
- Dividend Per Share
- ―
- Dividend Yield
- 0.28%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -0.03%
- Earnings Yield
- -0.29%
Stock Price Statistics
- Beta
- 0.19
- 52-Week Price Change
- -36.03%
- 50-Day Moving Average
- 146.70
- 200-Day Moving Average
- 172.76
- Relative Strength Index (RSI)
- 21.69
- Average Volume (3m)
- 148.01K
Important Dates
TCM Biotech International Corp. upcoming earnings date is Mar 24, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 06, 2026
- Next Earnings Date
- Mar 24, 2027
- Ex-Dividend Date
- ―
Financial Position
TCM Biotech International Corp. as a current ratio of 7.47, with Debt / Equity ratio of 4.07%
- Current Ratio
- 7.47
- Quick Ratio
- 6.26
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- -4.79
- Interest Coverage Ratio
- 21.59
Taxes
In the past 12 months, TCM Biotech International Corp. has paid 3.13M in taxes.
- Income Tax
- 3.13M
- Effective Tax Rate
- 0.14
Enterprise Valuation
TCM Biotech International Corp. EV to EBITDA ratio is -713.60, with an EV/FCF ratio of -2865.11.
- EV to Sales
- 8.50
- EV to EBITDA
- -713.60
- EV to Free Cash Flow
- -2865.11
- EV to Operating Cash Flow
- 1959.43
Balance Sheet
TCM Biotech International Corp. has TWD 1.20B in cash and marketable securities with TWD 24.88M in debt, giving a net cash position of TWD 1.17B billion.
- Cash & Marketable Securities
- TWD 1.20B
- Total Debt
- TWD 24.88M
- Net Cash
- TWD 1.17B
- Net Cash Per Share
- TWD 17.64
- Tangible Book Value Per Share
- TWD 29.12
Margins
Gross margin is 41.33%, with operating margin of -3.72%, and net profit margin of -2.72%.
- Gross Margin
- 41.33%
- Operating Margin
- -3.72%
- Pretax Margin
- -2.53%
- Net Profit Margin
- -2.72%
- EBITDA Margin
- -1.19%
- EBIT Margin
- -3.72%
